Suchergebnisse - "Brito, Dulce"

PubPharm (136)

51

Heart failure : The value of evidence-supported decision-making

Erschienen: 2020

von Brito, D.

CommentOn: Rev Port Cardiol. 2020 Jan;39(1):3-11. - PMID 31973946

52

Metabolite identification of ibuprofen biodegradation by Patulibacter medicamentivorans under aerobic conditions

enthalten in: Environmental technology | 2020

von Salgado, R. | Brito, D. | Noronha, J. | +5

53

Non‐invasive telemonitoring improves outcomes in heart failure with reduced ejection fraction : a study in high‐risk patients

enthalten in: ESC Heart Failure | 2020

von Nunes‐Ferreira, A. | Agostinho, J. | Rigueira, J. | +12

54

Protocol-based follow-up program for heart failure patients : Impact on prognosis and quality of life

Erschienen: 2019

von Agostinho, J. | Gonçalves, I. | Rigueira, J. | +13

CommentIn: Rev Port Cardiol (Engl Ed). 2019 Nov;38(11):765-766. - PMID 32029326

55

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge : primary results of the randomised TRANSITION study

enthalten in: European journal of heart failure | 2019

von Wachter, R. | Senni, M. | Belohlavek, J. | +123

CommentIn: Eur J Heart Fail. 2019 Aug;21(8):1008-1011. - PMID 31218805

56

Sacubitril/valsartan : A practical guide revisited

Erschienen: 2019

von Fonseca, C. | Brito, D. | Ferreira, J. | +4

CommentOn: Rev Port Cardiol. 2019 May;38(5):309-313. - PMID 30679005

57

Sacubitril/valsartan : A practical guide

Erschienen: 2019

von Fonseca, C. | Brito, D. | Ferreira, J. | +4

CommentIn: Rev Port Cardiol (Engl Ed). 2019 Jul;38(7):527-529. - PMID 31493946

58

Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy - An ancillary study of the Portuguese registry of hypertrophic cardiomyopathy

enthalten in: International journal of cardiology | 2019

von Lopes, L. | Brito, D. | Belo, A. | +2

59

Profiles of hospitalized patients with valvular heart disease : Experience of a tertiary center

Erschienen: 2018

von Esteves, A. | Brito, D. | Rigueira, J. | +5

CommentIn: Rev Port Cardiol (Engl Ed). 2018 Dec;37(12):999-1000. - PMID 30559035

60

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)

enthalten in: ESC heart failure | 2018

von Pouleur, A. | Anker, S. | Brito, D. | +22

ErratumIn: ESC Heart Fail. 2018 Dec;5(6):1199. - PMID 30570224